MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TTPY) today announced a new software licensing, marketing and development agreement with RaySearch Laboratories. Under the agreement, a suite of software products will be developed to facilitate the transfer of radiation therapy treatment plans between TomoTherapy® Hi·Art® treatment systems and conventional linear accelerators, and to extend the Hi·Art system’s treatment planning functionality. These developments will lead to improved workflow coordination, more efficient product utilization and increased patient treatment capacity.
